A new trading day began on Friday, with Twist Bioscience Corp (NASDAQ: TWST) stock price up 4.09% from the previous day of trading, before settling in for the closing price of $30.33. TWST’s price has ranged from $27.12 to $60.90 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 41.91%. Meanwhile, its annual earnings per share averaged 41.26%. With a float of $56.68 million, this company’s outstanding shares have now reached $59.86 million.
Considering the fact that the conglomerate employs 923 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 46.7%, operating margin of -57.86%, and the pretax margin is -55.03%.
Twist Bioscience Corp (TWST) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Twist Bioscience Corp is 5.40%, while institutional ownership is 110.04%. The most recent insider transaction that took place on Jun 06 ’25, was worth 27,082. Before that another transaction happened on Jun 06 ’25, when Company’s Officer proposed sale 225 for $31.75, making the entire transaction worth $7,144.
Twist Bioscience Corp (TWST) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 41.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.44% during the next five years compared to 1.70% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Here are Twist Bioscience Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.26, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.36 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Compared to the last year’s volume of 1.12 million, its volume of 1.34 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 67.41%. Additionally, its Average True Range was 2.14.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 15.77%, which indicates a significant decrease from 77.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.19% in the past 14 days, which was lower than the 68.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $34.72, while its 200-day Moving Average is $42.43. Nevertheless, the first resistance level for the watch stands at $32.64 in the near term. At $33.70, the stock is likely to face the second major resistance level. The third major resistance level sits at $34.57. If the price goes on to break the first support level at $30.71, it is likely to go to the next support level at $29.84. Now, if the price goes above the second support level, the third support stands at $28.78.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
With a market capitalization of 1.89 billion, the company has a total of 59,916K Shares Outstanding. Currently, annual sales are 312,970 K while annual income is -208,730 K. The company’s previous quarter sales were 92,790 K while its latest quarter income was -39,330 K.
